We therefore hypothesized: (1) the survival of the NexGen LPS-Flex prosthesis is better than standard NexGen LPS prosthesis; (2) knee function and range of motion after clinical assessment will be better in the NexGen LPS-Flex group; and (3) the incidence of osteolysis will be lower in the NexGen LPS-Flex prosthesis than standard NexGTne LPS prosthesis.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01422642?cond=%22Arthritis%22&lup_s=07/28/2011&lup_d=30
